Oklahoma has 13 labs left, and producers are shopping between them

An Oklahoma Watch investigation published July 20 documents lab shopping across Oklahoma's medical market: producers submitting the same product to lab after lab until one returns a favorable — which in practice means inflated — THC figure. OMMA has brought 29 enforcement actions against testing labs since the program began. The number of licensed labs serving the state has fallen from a 2022 peak of 31 to just 13 as of July 1.

The economics of why that happened are laid out bluntly by one of the people running a lab. "An honest lab in a state where there's any dishonest labs will not be profitable," MCR Labs vice president Yasha Kahn told the outlet. That is the entire mechanism in one sentence. If a competitor will certify a higher number, the lab that refuses loses the account, and eventually loses the business. Attorney Felina Rivera described the variance from the other side: "If you take a product to seven different labs, you're going to get seven different results."

The regulatory scaffolding meant to catch this hasn't been built. Oklahoma now requires 28 pesticide analytes, up from 13 before March 1 of this year. HB 3013 would have expanded that panel to 72 compounds; it never left committee. A patient advocate who tested roughly 40 products over two years after a severe reaction had a California lab find 19 chemicals sitting outside Oklahoma's required panel entirely. And the state's own quality-assurance lab — authorized by the legislature in 2023 for the specific purpose of running round-robin consistency checks across labs — still isn't fully accredited three years on.

Worth being precise about what is and isn't established here. Whether identical samples produce identical results across the remaining 13 labs has not been systematically tested, which is exactly the gap the state QA lab was supposed to fill. The advocate's health claims against a specific producer are contested and unresolved. What the reporting does establish is the incentive structure, and the incentive structure is unambiguous.

This is the supply-side version of a problem consumers meet as a number printed on a jar — the same THC-inflation dynamic Crushed has written about from the shopping end. Oklahoma shows where it leads: an entire testing sector consolidated down to 13 players, the honest ones squeezed hardest. If federal rescheduling ever produces uniform testing standards, Oklahoma's cultivator and processor base is looking at re-testing and reformulation costs nobody currently has priced in.